FINANCE ROUNDUP: Three IPOs and three VC rounds
Before they began their summer vacations, three biotechnology companies raised $62m in venture capital financing and three drug developers grossed $232m in initial public offerings.
Before they began their summer vacations, three biotechnology companies raised $62m in venture capital financing and three drug developers grossed $232m in initial public offerings.